BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 21436252)

  • 21. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.
    De Marco M; Gerdts E; Casalnuovo G; Migliore T; Wachtell K; Boman K; Dahlöf B; Olsen MH; Kizer JR; Devereux RB; de Simone G
    Am J Hypertens; 2013 Apr; 26(4):567-73. PubMed ID: 23391619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study.
    Kizer JR; Wiebers DO; Whisnant JP; Galloway JM; Welty TK; Lee ET; Best LG; Resnick HE; Roman MJ; Devereux RB
    Stroke; 2005 Dec; 36(12):2533-7. PubMed ID: 16254219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitral annular calcification and the risk of stroke in an elderly cohort.
    Benjamin EJ; Plehn JF; D'Agostino RB; Belanger AJ; Comai K; Fuller DL; Wolf PA; Levy D
    N Engl J Med; 1992 Aug; 327(6):374-9. PubMed ID: 1625711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
    Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
    Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial Fibrillation and Cardiovascular Outcomes in the Elderly.
    O'Neal WT; Salahuddin T; Broughton ST; Soliman EZ
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):907-13. PubMed ID: 27333877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
    Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
    J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Causes of death and influencing factors of atrial fibrillation patients undergoing anticoagulation therapy].
    Hua C; Jiang C; He L; Jia ZX; Lyu WH; Tang RB; Sang CH; Long DY; Dong JZ; Ma CS; Du X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):353-359. PubMed ID: 33874685
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
    Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study).
    Barasch E; Gottdiener JS; Marino Larsen EK; Chaves PH; Newman AB
    Am J Cardiol; 2006 May; 97(9):1281-6. PubMed ID: 16635596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    Yonsei Med J; 2015 Jan; 56(1):62-71. PubMed ID: 25510748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between mitral annular calcification and cardiovascular events: A meta-analysis.
    Wang TKM; Griffin BP; Xu B; Rodriguez LL; Popovic ZB; Gillinov MA; Pettersson GB; Desai MY
    Echocardiography; 2020 Nov; 37(11):1723-1731. PubMed ID: 32949217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of preoperative atrial fibrillation on mortality and cardiovascular outcomes of mechanical mitral valve replacement for rheumatic mitral valve disease.
    Wang B; Xu ZY; Han L; Zhang GX; Lu FL; Song ZG
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):513-9. PubMed ID: 22621873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
    Pilgrim T; Kalesan B; Zanchin T; Pulver C; Jung S; Mattle H; Carrel T; Moschovitis A; Stortecky S; Wenaweser P; Stefanini GG; Räber L; Meier B; Jüni P; Windecker S
    EuroIntervention; 2013 Jan; 8(9):1061-71. PubMed ID: 23339812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.